People who are not obese but overweight and at risk of serious cardiovascular events eligible for weekly jabs
The NHS in England is to offer more than 1 million people weight-loss drugs to reduce their risk of heart attacks and strokes.
Semaglutide (Wegovy) is already available on the health service for some people living with obesity, and also offered under the brand name Ozempic to treat type 2 diabetes.
Continue reading...Espace publicitaire · 300×250
